All lobbying filings

THE NICKLES GROUP, LLC

THE NICKLES GROUP, LLC filed a Q1 report for OMEROS CORPORATION on April 8, 2026.

Lobbying for OMEROS CORPORATION · Biopharmaceutical company.

All filings by THE NICKLES GROUP, LLC · Everything OMEROS CORPORATION has reported

Filing · LD-2 quarterly report Q1 report

Reporting period

1st Quarter 2026

Jan 1 - Mar 31 · Posted Apr 8, 2026

Money reported

None

Registrations and no-activity reports carry no figure.

Client based in

Washington

Official filing document

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 2

Medicare/Medicaid

Monitored separate payment policy for nonopioid alternatives. Monitored issues involving rare disease therapies.

Health Issues

Monitored issues related to rare pediatric disease and Priority Review Vouchers (PRVs).

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.